IL-26表达升高促进特应性皮炎角质形成细胞产生Th17和Th2相关细胞因子
特应性皮炎(AD)皮损中Th17细胞增多,但IL-26的作用未知。本研究发现AD皮损IL-26 mRNA和蛋白表达升高,IL-26通过STAT1/STAT3磷酸化促进角质形成细胞产生IL-8、IL-1β、CCL20、IL-33和β-防御素2,JAK抑制剂可阻断该过程;小鼠模型中IL-26注射加重AD并上调Th2/Th17细胞因子。IL-26可能桥接Th17与Th2反应。
要点
- AD皮损中IL-26表达升高,IL-26阳性细胞增多
- IL-26通过STAT1/STAT3促进角质形成细胞产生Th17/Th2相关因子
- JAK1/2/TYK2抑制剂可阻断IL-26诱导的细胞因子产生
核心结论
- IL-26在AD皮损中表达升高,可能通过促进角质形成细胞产生Th17和Th2相关细胞因子桥接两者反应,参与AD发病。
研究设计与样本
- 研究对比AD患者皮损与健康对照的IL-26表达,并在体外角质形成细胞和oxazolone诱导AD小鼠模型中验证IL-26功能。
主要发现
- AD皮损IL-26 mRNA水平较健康对照升高,免疫组化显示IL-26产生细胞增多。
- IL-26通过STAT1和STAT3磷酸化促进角质形成细胞产生IL-8、IL-1β、CCL20、IL-33和β-防御素2。
- JAK1、JAK2和TYK2选择性抑制剂阻断IL-26诱导的角质形成细胞细胞因子产生。
- 注射IL-26加重oxazolone诱导的AD小鼠模型,并上调Th2和Th17细胞因子表达。
临床怎么用
- JAK抑制剂可能通过阻断IL-26下游信号减轻AD炎症,但需临床验证。
局限性
- 机制主要基于体外和动物模型,人体证据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Whereas atopic dermatitis (AD) is considered as a T helper 2 (Th2)-centered disease, IL-17-producing Th (Th17) cells are also activated in AD lesional skin. However, the relationship between Th17 responses and Th2 responses in AD is still to be elucidated. Although Th17 cells are increased in AD skin, the expression and function of IL-26, which is also produced by Th17 cells, in AD are still unknown. In this report, we demonstrated that IL-26 mRNA expression levels were elevated in AD lesional skin compared with healthy controls and that IL-26-producing cells were increased in AD lesional skin by immunohistochemistry. Furthermore, IL-26 promoted IL-8, IL-1β, chemokine (C-C motif) ligand 20, IL-33, and β-defensin 2 production in keratinocytes through phosphorylation of signal transducer and activator of transcription 1 and signal transducer and activator of transcription 3. Selective JAK inhibitors for JAK1, JAK2, and tyrosine kinase 2 blocked IL-26-induced cytokine production in keratinocytes. We also showed that injection of IL-26 exacerbated an oxazolone-induced AD mouse model and upregulated Th2 and Th17 cytokine expression in vivo. Because previous studies indicate that the above molecules induced by IL-26 can promote Th17 and/or Th2 immune responses, IL-26 may play an important role for bridging between Th17 and Th2 responses, resulting in the development of AD.
引用
- Kamijo H, Miyagaki T, Hayashi Y, et al. Increased IL-26 Expression Promotes T Helper Type 17- and T Helper Type 2-Associated Cytokine Production by Keratinocytes in Atopic Dermatitis. J Invest Dermatol. 2019. PMID: 31465744. doi:10.1016/j.jid.2019.07.713
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。